ImageneBio (IMA) Interest Expenses (2022 - 2023)
ImageneBio's (IMA) quarterly Interest Expenses came in at $14000.0 in Q4 2023, up 566.67% year-on-year from $2100.0 in Q4 2022, and up 600.0% quarter-over-quarter from $2000.0 in Q3 2023.
ImageneBio (IMA) Interest Expenses (2022 - 2023) Analysis & Trends
ImageneBio has disclosed Interest Expenses across 2 years of filings, most recently posting $14000.0 for Q4 2023.
- Interest Expenses for Q4 2023 came in at $14000.0, up 566.67% year-over-year; the trailing twelve-month figure through Sep 2024 was $14000.0 (up 180.0% YoY), and the FY2023 annual result was $22000.0, up 120.0% from the prior year.
- Interest Expenses came in at $14000.0 for Q4 2023 at ImageneBio, up from $2000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $49000.0 in Q1 2022 to a low of -$3000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Mar 31, 2022 | 49,000.00 |